NAMPT
Nicotinamide phosphoribosyltransferase
Also known as: NAMPT_HUMAN, PBEF, PBEF1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43490
- Gene
- NAMPT
- Ensembl
- ENSG00000105835
- Chromosome
- 7
- Canonical length
- 491 aa
- Protein class
- Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nuclear speckles,Cell Junctions
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, one step in the biosynthesis of nicotinamide adenine dinucleotide. The protein belongs to the nicotinic acid phosphoribosyltransferase (NAPRTase) family and is thought to be involved in many important biological processes, including metabolism, stress response and aging. This gene has a pseudogene on chromosome 10. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>P43490|NAMPT
1 MNPAAEAEFN ILLATDSYKV THYKQYPPNT SKVYSYFECR EKKTENSKLR KVKYEETVFY
61 GLQYILNKYL KGKVVTKEKI QEAKDVYKEH FQDDVFNEKG WNYILEKYDG HLPIEIKAVP
121 EGFVIPRGNV LFTVENTDPE CYWLTNWIET ILVQSWYPIT VATNSREQKK ILAKYLLETS
181 GNLDGLEYKL HDFGYRGVSS QETAGIGASA HLVNFKGTDT VAGLALIKKY YGTKDPVPGY
241 SVPAAEHSTI TAWGKDHEKD AFEHIVTQFS SVPVSVVSDS YDIYNACEKI WGEDLRHLIV
301 SRSTQAPLII RPDSGNPLDT VLKVLEILGK KFPVTENSKG YKLLPPYLRV IQGDGVDINT
361 LQEIVEGMKQ KMWSIENIAF GSGGGLLQKL TRDLLNCSFK CSYVVTNGLG INVFKDPVAD
421 PNKRSKKGRL SLHRTPAGNF VTLEEGKGDL EEYGQDLLHT VFKNGKVTKS YSFDEIRKNA
481 QLNIELEAAH HLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAMPT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 339 nTPM
Expression across tissuesHPA
Tissue
- appendix: 339 nTPM
- bone marrow: 295 nTPM
- urinary bladder: 264 nTPM
- liver: 224 nTPM
- esophagus: 214 nTPM
- adipose tissue: 198 nTPM
Single-cell type
- neutrophils: 41,123 nCPM
- monocytes: 4,892 nCPM
- salivary acinar cells: 2,531 nCPM
- esophageal apical cells: 2,255 nCPM
- cdc: 1,756 nCPM
- macrophages: 1,560 nCPM
Immune cell
- neutrophil: 282 nTPM
- basophil: 40 nTPM
- non-classical monocyte: 31 nTPM
- intermediate monocyte: 22 nTPM
- eosinophil: 16 nTPM
- T-reg: 7.1 nTPM
Brain region
- medulla oblongata: 153 nTPM
- thalamus: 93 nTPM
- cerebral cortex: 68 nTPM
- pons: 48 nTPM
- midbrain: 44 nTPM
- choroid plexus: 38 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.97
- DepMap mean gene effect
- -0.44
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell signaling
- circadian regulation of gene expression
- inflammatory response
- NAD+ biosynthetic process
- NAD+ biosynthetic process via the salvage pathway
- NADP+ biosynthetic process
- nicotinamide metabolic process
- nicotinate metabolic process
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cell population proliferation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of gene expression
- positive regulation of transcription by RNA polymerase II
- signal transduction
Molecular functions
- cytokine activity
- identical protein binding
- nicotinamide phosphoribosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aldolase-type TIM barrel
- Nicotinate phosphoribosyltransferase-like, C-terminal
- Nicotinamide phosphoribosyl transferase
- Nicotinate/nicotinamide phosphoribosyltransferase
- Nicotinamide phosphoribosyltransferase, N-terminal domain
- Nicotinate phosphoribosyltransferase (NAPRTase) family
- Nicotinamide phosphoribosyltransferase, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NAMPT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAMPT as an antibody target. Whether an autoantibody or antibody against NAMPT could matter depends on whether native NAMPT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAMPT is annotated as secreted, so native NAMPT circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NAMPT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...